Oxymorphone Extended-Release Tablets and Pasireotide Extended-Release Injection
Determining the interaction of Oxymorphone Extended-Release Tablets and Pasireotide Extended-Release Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oxymorphone Extended-Release Tablets-Pasireotide Injection
- Oxymorphone Extended-Release Tablets-Pasireotide Subcutaneous
- Oxymorphone Extended-Release Tablets-Patanase
- Oxymorphone Extended-Release Tablets-Patiromer
- Oxymorphone Extended-Release Tablets-Patiromer Sorbitex Calcium
- Oxymorphone Extended-Release Tablets-Pavacot
- Pasireotide Extended-Release Injection-Oxymorphone Hydrochloride
- Pasireotide Extended-Release Injection-Oxymorphone Injection
- Pasireotide Extended-Release Injection-Oxymorphone Tablets
- Pasireotide Extended-Release Injection-Oxytocin
- Pasireotide Extended-Release Injection-Oxytocin Intravenous, Intramuscular
- Pasireotide Extended-Release Injection-Oxytrol